Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
9,822 | $4.15 | $40,761 | 797,680 (Indirect Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
2,777 | $4.15 | $11,525 | 42,050 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
2,681 | $4.15 | $11,126 | 375,828 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Politi Jason Chief Technical Ops. Off. |
3,235 | $4.15 | $13,425 | 37,356 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
3,350 | $4.15 | $13,903 | 47,030 (Direct) |
View |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer |
2,189 | $4.15 | $9,084 | 25,657 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-03 4:30 pm |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
555 | $5.64 | $3,130 | 7,255 (Direct) |
View |
| 2024-05-14 Purchase |
2024-05-15 5:30 pm |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
76,000 | $6.26 | $475,760 | 342,509 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
1,514 | $8.24 | $12,475 | 18,604 (Direct) |
View |
| 2023-12-01 Purchase |
2023-12-05 4:30 pm |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
1,800,000 | $10 | $18,000,000 | 12,168,489 (Indirect) |
View |
| 2023-11-29 Sale |
2023-12-01 4:30 pm |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
554 | $11.45 | $6,343 | 7,810 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
33,000 | $0 | 797,680 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
18,630 | $0 | 42,050 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
9,000 | $0 | 375,828 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Politi Jason Chief Technical Ops. Off. |
17,630 | $0 | 37,356 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
11,250 | $0 | 47,030 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer |
14,680 | $0 | 25,657 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
378,000 | $0 | 378,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Politi Jason Chief Technical Ops. Off. |
265,000 | $0 | 265,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
758,000 | $0 | 758,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer |
265,000 | $0 | 265,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
265,000 | $0 | 265,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
265,000 | $0 | 265,000 (Direct) |
View |
| 2024-12-04 Gift |
2024-12-04 4:30 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
30,000 | $0 | 675,502 (Direct) |
View |
| 2024-11-29 Exercise |
2024-12-03 4:30 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
1,875 | $0 | 7,255 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-02 07:30 am |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
30,000 | $2.87 | 1,248,430 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-02 07:30 am |
N/A 2030-09-15 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
30,000 | $0 | 1,248,430 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
136,139 | $0 | 136,139 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | Mikhail Sheila Director |
136,139 | $0 | 136,139 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director |
136,139 | $0 | 136,139 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | Cumbo Alexander Director |
136,139 | $0 | 136,139 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | Tatsis Ourania Director |
267,541 | $0 | 267,541 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | Morrison Jodie Pope Director |
267,541 | $0 | 267,541 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | COATS LONNEL Director |
136,139 | $0 | 136,139 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | MacLean Michael F Director |
136,139 | $0 | 136,139 (Direct) |
View |
Ownership |
2024-06-28 07:30 am |
N/A N/A |
Verve Therapeutics Inc. | VERV | Politi Jason Chief Technical Ops. Off. |
0 | $0 | 394,177 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:05 pm |
N/A 2034-06-20 |
Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer |
32,000 | $0 | 32,000 (Direct) |
View |
Ownership |
2024-06-25 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Lister Troy Chief Scientific Officer |
0 | $0 | 260,516 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
3,315 | $0 | 18,604 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A 2034-02-13 |
Verve Therapeutics Inc. | VERV | Ashe Andrew D. See Remarks |
186,000 | $0 | 186,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A 2034-02-13 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
658,000 | $0 | 658,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A 2034-02-13 |
Verve Therapeutics Inc. | VERV | Nickerson Joan Chief Administrative Officer |
149,000 | $0 | 149,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A 2034-02-13 |
Verve Therapeutics Inc. | VERV | Fiedorek Fred T. Chief Medical Officer |
112,000 | $0 | 112,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A 2034-02-13 |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A 2034-02-13 |
Verve Therapeutics Inc. | VERV | Bellinger Andrew Chief Scientific Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2022-11-07 Ownership |
2024-02-09 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | ADELMAN BURT A Director |
409,626 | $0 | 428,326 (Indirect) |
View |
Ownership |
2023-12-05 4:50 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | GV 2023 GP L.L.C. GV 2023 GP L.P. GV 2023 L.P. Alphabet Inc. Member of 10% Group |
0 | $0 | 1,800,000 (Indirect) |
View |
| 2023-11-29 Exercise |
2023-12-01 4:30 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer |
1,875 | $0 | 7,810 (Direct) |
View |